A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/19/2002	CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/19/2002	CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/19/2002	CA2219502C Methods and formulations for modulating the human sexual response
11/19/2002	CA2156512C Treatment of androgen-associated baldness using antisense oligomers
11/19/2002	CA2154432C Cosmetic and/or dermatologic composition containing thermal or mineral water and an anti-acne and anti-aging active ingredient
11/19/2002	CA2153546C Periwinkle grain extract and composition containing the same
11/19/2002	CA2112061C Alkyl substituted heterocyclic compounds
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2066134C Complexes of polyadenylic acid with polyuridylic acid
11/19/2002	CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/19/2002	CA2050970C Pharmaceutical compositions containing furan derivatives
11/19/2002	CA2044143C Method of preventing or limiting reperfusion damage
11/19/2002	CA2038934C Anti-cancer compounds
11/18/2002	WO2001087855A1 Triazole derivatives
11/18/2002	CA2381829A1 A method for tumor treatment with fumagillol derivatives
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/15/2002	WO2001090053A1 Diphenylmethane derivatives
11/15/2002	CA2409144A1 Diphenylmethane derivatives
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090585A2 Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090555A1 A method for transfection of rna using electrical pulses
11/14/2002	WO2002090543A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/14/2002	WO2002090534A1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090515A2 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090493A2 Δ4-desaturase genes and uses thereof
11/14/2002	WO2002090390A1 Hyaluronic acid containing bioconjugates : targeted delivery of anti-cancer drugs to cancer cells
11/14/2002	WO2002090375A2 Liver x receptor agonists
11/14/2002	WO2002090364A1 Cephem compounds
11/14/2002	WO2002090363A1 ANHYDROUS CRYSTAL OF ss-LACTAM COMPOUND AND METHOD FOR PREPARATION THEREOF
11/14/2002	WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002	WO2002090358A1 Disubstituted 7,9-guaninium halides as telomerase inhibitors
11/14/2002	WO2002090357A1 Disubstituted 1,7-guanines
11/14/2002	WO2002090356A2 Method for the production of zolpidem
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090354A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002	WO2002090351A1 Process for producing carbostyril derivative
11/14/2002	WO2002090350A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
11/14/2002	WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002	WO2002090348A1 Sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002	WO2002090337A1 Sulfonamides
11/14/2002	WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002	WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002	WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
11/14/2002	WO2002090304A1 Stable solution of reduced coenzyme q
11/14/2002	WO2002089945A2 Processes and apparatus for extraction of active substances and enriched extracts from natural products
11/14/2002	WO2002089942A1 Formation of small crystals
11/14/2002	WO2002089918A1 Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear
11/14/2002	WO2002089917A2 Dermatological formulations
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089853A2 Compositions having enhanced pharmacokinetic characteristics
11/14/2002	WO2002089849A1 Compositions and delivery systems for administration of a local anesthetic agent
11/14/2002	WO2002089848A2 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
11/14/2002	WO2002089847A1 Cytostatic effects of fatty acid synthase inhibition
11/14/2002	WO2002089846A1 Topical medication for burns and wounds
11/14/2002	WO2002089845A1 Remedies for sepsis
11/14/2002	WO2002089842A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents
11/14/2002	WO2002089835A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089825A1 Medicinal herbal compounds for the prevention and treatment of diabetes
11/14/2002	WO2002089824A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/14/2002	WO2002089821A1 Ophthalmic liquid preparation and liquid preparation for contact lens
11/14/2002	WO2002089820A1 Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption
11/14/2002	WO2002089819A1 Glycoconjugates and uses thereof
11/14/2002	WO2002089818A1 Use of sucralfate for the treatment of cervical erosion
11/14/2002	WO2002089817A2 Anti-virus agent
11/14/2002	WO2002089816A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
11/14/2002	WO2002089815A2 Disinfecting and solubilizing steroid compositions
11/14/2002	WO2002089814A1 17-METHYLENE-ANDROSTAN-3α-OL ANALOGS AS CRH INHIBITORS
11/14/2002	WO2002089813A2 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
11/14/2002	WO2002089811A1 Benzo[d]azepine derivatives as 5-ht6 receptor antagonists.
11/14/2002	WO2002089809A1 Medicinal uses of hydrazones and hydrazines
11/14/2002	WO2002089808A1 Novel use of 2-phenyl-substituted imidazotriazinones
11/14/2002	WO2002089807A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection
11/14/2002	WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002	WO2002089805A2 Use of regularly scheduled high dose intravenous methotrexate therapy
11/14/2002	WO2002089804A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/14/2002	WO2002089803A1 Composition for iontophoresis
11/14/2002	WO2002089802A2 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
11/14/2002	WO2002089801A1 Use of benzothiophenes to treat and prevent prostave cancer
11/14/2002	WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002	WO2002089799A2 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/14/2002	WO2002089798A2 Method and compositions for treating migraines
11/14/2002	WO2002089797A1 Treatment of adhd
11/14/2002	WO2002089796A2 Methods for selective immunomodulation using pimecrolimus
11/14/2002	WO2002089795A1 Method for treatment of tumors using nordihydroguaiaretic acid derivatives

1 ... 5648 5649 5650 5651 5652 5653 5654 5655 5656 5657 5658 5659 5660 5661 5662 5663 5664 5665 5666 5667 5668 ... 7860